By RMIT Advanced Manufacturing Precinct and Centre for Additive Manufacture The 4th International Forum on Additive Manufacturing, delivered virtually on 9 September, 2020 in Melbourne, Australia proved by all accounts to be a great success. The Forum general chair Professor Milan Brandt of the Centre for Additive Manufacturing, RMIT University attracted a number of international,…
The University of Sydney has announced Phase 1 human trials of Australia’s first DNA-based Covid-19 vaccine.
For the first time in years, our dependence on manufactured goods from outside of Australia has been questioned – all of a sudden, the kilometres in a supply chain really matter. By Peter Rowland.
Over the next few years, science and technology will have a vital role in supporting Australia’s economy as it strives to recover from the coronavirus pandemic.
Port Melbourne-based 3DMeditech has earned a $3.7 million contract for nasopharyngeal swab kits, which will be delivered to the National Medical Stockpile up to March next year and be used to test for Covid-19.
CSL will manufacture approximately 85 million doses of two Covid-19 vaccines, beginning early next year, if their clinical trials are successful.
Hygiene, cleaning and infection control products firm Whiteley Corporation is next in @AuManufacturing’s Australia’s niche champions series. Cole Latimer speaks to chairman Dr Greg Whiteley about having to stay ahead on the science.
Bosch Australia Manufacturing Solutions has earned a contract to automate handling, inspection and storage of blood plasma products at CSL Behring’s Broadmeadows site.
A homegrown solution aims to use kangaroo tissue to improve on current options for ligament surgeries. Brent Balinski spoke to Dr Nick Hartnell of BLT about the project’s progress.
In the fourth day of our Australia’s niche champions series, Stephen Tomisich discusses following a global niche strategy.